Johnson & Johnson announced that it would pay US$1 billion to Aragon Pharmaceuticals and its experimental drugs for prostate cancer treatment.
Tags: Johnson & Johnson
Bidding for J&J's Ortho Clinical Diagnostics unit heats up
Many private equity firms and partnerships are in the process of formulating their bids for diagnostic unit of Johnson&Johnson.
J&J receives private equity offers
Johnson & Johnson received numerous preliminary offers from hedge funds interested in acquiring its Ortho Clinical Diagnostics unit, said a Reuters report.
Sources: J&J puts clinical diagnostics unit on sale
Johnson & Johnson had launched a sale process for its Ortho Clinical Diagnostics unit valued at USD5 billion.
Energizer set to acquire Johnson & Johnson feminine care brands
Energizer Holdings planned to acquire Johnson & Johnson's feminine care line for US$185 million.
Latest News
Elan Pharmaceuticals has decided to sell itself after the many tendered offers it has received. (Photo : Reuters)The image is the logo of Elan Pharmaceuticals.
